Recruitment

Recruitment Status
Active, not recruiting
Estimated Enrollment
36

Summary

Conditions
  • Melanoma
  • Skin Cancer
Type
Interventional
Phase
Phase 1
Design
Allocation: N/AIntervention Model: Sequential AssignmentMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT02032810
Collaborators
Novartis
Investigators
Principal Investigator: Nikhil Khushalani, M.D. H. Lee Moffitt Cancer Center and Research Institute